Silo Pharma (SILO) Current Assets (2010 - 2026)
Silo Pharma (SILO) posted Current Assets of $6.8 million for Q1 2026, down 7.91% sequentially from $7.4 million in Q4 2025, and up 21.4% YoY from $5.6 million in Q1 2025.
Silo Pharma (SILO) Current Assets (2010 - 2026) Analysis & Trends
Silo Pharma has reported Current Assets for 14 years, with the latest figure at $6.8 million in Q1 2026.
- Quarterly Current Assets rose 21.4% year-over-year to $6.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.8 million (up 21.4% YoY) and the FY2025 annual result came in at $7.4 million, up 3.88% from the prior year.
- Current Assets retreated to $6.8 million in Q1 2026 per SILO's latest filing, from $7.4 million in the prior quarter.
- Over five years, Current Assets peaked at $12.9 million in Q3 2022 and troughed at $5.6 million in Q1 2025.
- A 5-year average of $8.4 million and a median of $7.7 million in 2024 frame the typical range for Current Assets.
- The sharpest annual moves came in 2022 and 2024: Current Assets jumped 79.87% in 2022, then sank 37.21% in 2024.
- Over 5 years, Current Assets stood at $11.6 million in 2022, then tumbled by 33.62% to $7.7 million in 2023, then retreated by 7.42% to $7.1 million in 2024, then grew by 3.88% to $7.4 million in 2025, then decreased by 7.91% to $6.8 million in 2026.
- According to Business Quant data, Current Assets over the past three periods registered $6.8 million, $7.4 million, and $6.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.71 Bn | 131.86 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.55 Bn | 78.55 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.26 Bn | 60.07 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 59.81 Bn | 54.67 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.16 Bn | 37.06 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.87 Bn | 28.56 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.13 Bn | 9.74 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.31 Bn | 26.47 Bn | - | 1.76 Bn |
| 10 | Silo Pharma | 2.92 Mn | 2.92 Mn | - | 5.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.71 Mn |
| Mar 31, 2026 | 6.80 Mn |
| Dec 31, 2025 | 7.39 Mn |
| Sep 30, 2025 | 6.16 Mn |
| Jun 30, 2025 | 6.37 Mn |
| Mar 31, 2025 | 5.60 Mn |
| Dec 31, 2024 | 7.11 Mn |
| Sep 30, 2024 | 8.26 Mn |
| Jun 30, 2024 | 7.73 Mn |
| Mar 31, 2024 | 6.88 Mn |
| Dec 31, 2023 | 7.68 Mn |
| Sep 30, 2023 | 8.92 Mn |
| Jun 30, 2023 | 10.18 Mn |
| Mar 31, 2023 | 10.95 Mn |
| Dec 31, 2022 | 11.57 Mn |
| Sep 30, 2022 | 12.91 Mn |
| Jun 30, 2022 | 8.95 Mn |
| Mar 31, 2022 | 9.62 Mn |
| Dec 31, 2021 | 10.40 Mn |
| Sep 30, 2021 | 11.30 Mn |